To Live or to Die: Prosurvival Activity of PPARgamma in Cancers.
The role of PPARgamma in tumorigenesis is controversial. In this article, we review and analyze literature from the past decade that highlights the potential proneoplastic activity of PPARgamma. We discuss the following five aspects of the nuclear hormone receptor and its agonists: (1) relative expression of PPARgamma in human tumor versus normal tissues; (2) receptor-dependent proneoplastic effects; (3) impact of PPARgamma and its agonists on tumors in animal models; (4) clinical trials of thiazolidinediones (TZDs) in human malignancies; (5) TZDs as chemopreventive agents in epidemiology studies. The focus is placed on the most relevant in vivo animal models and human data. In vitro cell line studies are included only when the effects are shown to be dependent on the PPARgamma receptor.
Wang
Y Lynn
YL
Molecular Hematopathology Laboratory, Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
Miao
Qi
Q
Trends Endocrinol Metab. 2002 Mar;13(2):75-8
11854022
Nat Med. 2003 Oct;9(10):1265-6
12960963
Nat Med. 1998 Sep;4(9):1053-7
9734399
J Immunol. 2007 Apr 1;178(7):4039-50
17371958
J Neurochem. 2006 Apr;97(2):435-48
16539667
Br J Clin Pharmacol. 1998 Jan;45(1):31-5
9489591
Gastroenterology. 2003 Feb;124(2):361-7
12557142
J Clin Invest. 2003 Sep;112(6):945-55
12975479
Cancer Res. 2005 Mar 15;65(6):2251-9
15781638
Nat Med. 1998 Sep;4(9):1046-52
9734398
Am J Pathol. 2007 Feb;170(2):722-32
17255338
Lancet Oncol. 2003 Oct;4(10):605-15
14554238
Cancer Res. 2001 Jul 1;61(13):5307-10
11431375
J Biol Chem. 1995 Jun 2;270(22):12953-6
7768881
Cardiovasc Res. 2004 Apr 1;62(1):135-44
15023560
Cancer Res. 1999 Nov 15;59(22):5671-3
10582681
Cancer J. 2002 Sep-Oct;8(5):395-9
12416897
Biochem Biophys Res Commun. 2001 Sep 28;287(3):727-32
11563856
J Immunol. 2006 Sep 15;177(6):3737-45
16951334
Cell. 1995 Dec 1;83(5):813-9
8521498
N Engl J Med. 2007 Aug 30;357(9):844-6
17687124
Science. 2000 Aug 25;289(5483):1357-60
10958784
Neuroscience. 2005;130(3):685-96
15590152
Mol Cell. 1999 Jun;3(6):799-804
10394368
N Engl J Med. 2007 Jul 5;357(1):28-38
17551159
Oncogene. 2006 May 4;25(19):2736-47
16314832
J Biol Chem. 2001 Jul 6;276(27):25049-56
11292834
J Pharm Biomed Anal. 1985;3(5):483-7
16867662
Clin Cancer Res. 2005 Jun 1;11(11):4012-21
15930335
Int J Cancer. 2003 May 1;104(5):597-602
12594814
Prostate. 2002 May 1;51(2):108-16
11948965
Mol Pharmacol. 2008 Mar;73(3):709-17
18055759
Br J Cancer. 2000 Nov;83(10):1394-400
11044367
Nat Med. 1998 Sep;4(9):1058-61
9734400
Cancer Res. 2005 Jun 1;65(11):4769-74
15930296
N Engl J Med. 2007 Jun 14;356(24):2457-71
17517853
Mol Cell. 1998 Feb;1(3):465-70
9660931
Oncogene. 2004 Jan 8;23(1):100-8
14712215
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):1983-93
16609007
Clin Cancer Res. 2007 Jan 1;13(1):246-52
17200362
Clin Cancer Res. 2006 Nov 1;12(21):6444-51
17085658
Lab Invest. 2003 Dec;83(12):1715-21
14691289
Breast Cancer Res Treat. 2003 Jun;79(3):391-7
12846423
Am J Nephrol. 2003 Jul-Aug;23(4):267-76
12840602
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13771-6
12370429
J Neurosci. 2004 Feb 11;24(6):1312-8
14960602
J Biol Chem. 2002 Aug 30;277(35):31781-8
12082115
Mol Endocrinol. 2002 Dec;16(12):2793-801
12456800
Cancer Res. 1999 Jun 1;59(11):2739-46
10364000
Nature. 2000 Jan 6;403(6765):103-8
10638762
Cancer Res. 2000 Nov 1;60(21):6201-7
11085546
J Clin Oncol. 2007 Apr 20;25(12):1476-81
17442990
Eur J Neurosci. 2006 Sep;24(6):1653-63
17004929
J Neurochem. 2007 Apr;101(1):41-56
17394460
J Med Chem. 2000 Feb 24;43(4):527-50
10691680
J Biol Chem. 2005 Mar 11;280(10):9604-9
15632188
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10990-5
10984506
Korean J Gastroenterol. 2004 May;43(5):291-8
15156115
J Biol Chem. 2002 May 17;277(20):17830-5
11884400
J Clin Endocrinol Metab. 2005 Jul;90(7):3886-96
15886257
Br J Cancer. 2005 Jan 17;92(1):113-9
15583697
Br J Cancer. 2003 Oct 20;89(8):1409-12
14562008
FASEB J. 2002 Jul;16(9):1027-40
12087064
Gene. 1999 Jun 24;234(1):87-91
10393242
Cancer. 2004 Oct 1;101(7):1569-74
15468186
Front Biosci. 2008 Jan 01;13:1813-26
17981670
Am J Physiol Cell Physiol. 2005 Apr;288(4):C899-905
15590897
Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):237-41
8990192
Genes Dev. 2004 Mar 1;18(5):528-40
15037548
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8806-11
9671760
Trends Biochem Sci. 1999 Feb;24(2):68-72
10098401
J Clin Endocrinol Metab. 2001 May;86(5):2170-7
11344222
Carcinogenesis. 2004 Sep;25(9):1747-55
15073042
Surgery. 2006 Dec;140(6):960-6; discussion 966-7
17188145
Eur J Pharmacol. 2008 Feb 2;580(1-2):80-6
18054911
J Med Chem. 1996 Feb 2;39(3):665-8
8576907
Int J Cancer. 2005 Sep 10;116(4):495-9
15818612